November 14, 2017 Regulatory Promore Pharma Signs Out-licensing Agreement with Transdermal Therapeutic Technologies for its Peptide DPK-060
October 30, 2017 Non Regulatory Promore Pharma Completes Extensive European Collaboration Regarding DPK-060
September 12, 2017 Non Regulatory Promore Pharma presents at the symposium for hard-to-heal wounds in connection with Nordic Life Science Days
June 26, 2017 Non Regulatory New share issue in Promore Pharma raises 76 MSEK ahead of listing on Nasdaq First North
June 7, 2017 Non Regulatory Promore Pharma Carries Out a Share Issue Prior to Listing on Nasdaq First North
April 26, 2017 Non Regulatory Promore Pharma AB elects Marianne Dicander Alexandersson as New Board Member and outlines plans for IPO